Menu
Global
简体中文
繁体中文
English
Home
About Us
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
Oncology
Digestive
NASH
Investor
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
Contact Us
Address
Contact Information
Adverse drug reaction report
Join XZenith
Our Culture
Careers
Benefit
Talent Development
Employee style
Investor relations
XZenith
02575.HK
Max
Min
Turnover (10,000 hands)
Transaction volume (Billion)
As of2025-10-13 20:20:20 Hong Kong stock market time*The quotes are delayed by 15 minutes or more. Source: Sina Weibo.
Announcements and Circulars
More
Financial Report
More
Corporate governance
More
Investor Calendar
More
Company Information
More
Prospectus
More
Investor contact
Investor Relations
Phone
+86-010-5765 4567
Email
ir@xuanzhubio.com
Home
About Us
+
Company Introduction
Development History
Leadership Team
Honor and Qualification
Industry Chain
Corporate Culture
R & D
+
Therapeutic Area
Technology Platform
Innovative Pipeline
Partnering
Products
+
Oncology
Digestive
NASH
Investor
+
Stock Information
Announcements and Circulars
Financial Report
Corporate governance
Investor Calendar
Company Information
Prospectus
Investor Relations
News
+
Contact Us
+
Address
Contact Information
Adverse drug reaction report
Join XZenith
+
Our Culture
Careers
Benefit
Talent Development
Employee style